The Rise of GIP: From Biology to Medicine

13 min•16 maj 2025

Om avsnittet

Delve into the evolving story of GIP-based therapies and their role in type 2 diabetes care. In this episode, our expert guests explore how dual and triple agonists like tirzepatide are reshaping obesity and metabolic control, and why GIP is gaining renewed attention in diabetes pharmacology.

You can also explore each speakers' profiles as well as watch each speaker’s Lecturesession from the EASD Annual Meeting 2024 for deeper insights into incretin science, clinical outcomes, and next-generation therapies:

Prof. Michael Nauck's Profile and EASD 2024 Lecture
Dr. Alice Adriaenssens' Profile and EASD 2024 Lecture

The Rise of GIP: From Biology to Medicine

Om avsnittet

Fler avsnitt

The EASD's First Clinical Guideline: Assessment and Management of Diabetes Distress

Hot Topics for People Living with Diabetes - Off Label Use, Sensors and Stigma

When to Exercise and Does it Matter?

Harvesting the Seeds from Funding Type 1 Diabetes Research

Challenges and Opportunities - How EASD Turned Global

AI in Diabetes Care

Global Collaboration: East - West Exchange to Learn from Each Other

What's the Metholodology behind Clinical Guidelines?

Spotlight at Guidelines on Continuous Glucose Monitoring in Type 2 Diabetes

EASD 2025: Golden Anniversary - 50 years of attending the EASD Annual Meeting